|
Renovist IiDrug - Renovist Ii The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Diatrizoate Meglumine; Diatrizoate Sodium
Strength -
28.5%;29.1%
Applicant -
BRACCO
New Drug Application (NDA) Number -
010040
Product Number -
019
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bracco Diagnostics Inc
Renovist Ii
Hypaque-m,75% 50%;25% Injectable; Injection
Hypaque-m,90% 60%;30% Injectable; Injection Md-60 52%;8% Injectable; Injection Md-76 66%;10% Injectable; Injection Md-76r 66%;10% Injectable; Injection Renocal-76 66%;10% Injectable; Injection Renografin-60 52%;8% Injectable; Injection Renografin-76 66%;10% Injectable; Injection Renovist 34.3%;35% Injectable; Injection Renovist Ii 28.5%;29.1% Injectable; Injection NewDrugInformation |